When insulin/GLP-1RA fixed-ratio combinations are compared with basal insulin, a superiority in reducing HbA1c is observed, with overall benefit also in weight neutrality or weight loss, reduced hypoglycemia risk, and reduced insulin-dose requirement [19, 25,26,27, 30, 31]
A game-changer in obesity treatment Initially developed for type 2 diabetes, GLP-1 receptor agonists work by mimicking hormones in the gut to regulate blood sugar levels and appetite
Typical starting doses range from 0.5 g to 2 g (10 - 40 mL of the 50 mg/mL solution) given intermittently (e.g., weekly)
Dingens, A
Variants in a variety of ion channels have been determined to be causal in many individuals with multiple different paroxysmal disorders, including hemiplegic migraine, epilepsy, hypokalemic periodic paralysis, myotonia congenita, episodic ataxia, long QT syndrome, and malignant hyperthermia 33, 6471